Pharmaceutical Regulation and Product Liability

Friday 21 April 2006 09:00 to 18:00

Location

Atlantic House, Holborn Viaduct, London EC1A 2FG
 

Participants

Chairs:

  • Mr Justice Underhill
  • Jeremy Stuart-Smith QC, 4 New Square;
  • Sarah Houlton, Global Correspondent, Pharmaceutical Executive Magazine;
  • John Meltzer, Lovells

Speakers:

  • Paula M. Stannard, Acting General Counsel, U.S Department of The Health & Human Services
  • Professor Salvatore Vincenzo, Head of Legal, EMEA
  • Dr Peter Feldschreiber, MHRA
  • Jeffrey Bucholtz, US Department of Justice
  • Simon Gregor, Director of Communications, Medicines and Healthcare products Regulatory Agency
  • Andrew Baum, Pharmaceutical Research Team, Morgan Stanley
  • Martyn Day, Leigh Day and Co
  • Nicholas Diamand, Lieff, Cabraser, Heimann & Bernstein, LLP, New York
  • Ina Brock, Lovells
  • Joe Cyr, Lovells
  • Duncan Fairgrieve, British Institute of International and Comparative Law
  • Stefan Lenze, British Institute of International and Comparative Law/Lovells
  • Professor Marco Bona, Università «Bocconi» di Milano
  • Rob Weiner, Arnold & Porter
  • Leigh-Ann Mulcahy, 4 New Square
  • Ian Dodds-Smith, Arnold Porter
  • Dr Grant Castle, Covington & Burling
  • Arundel McDougall, Ashurst
  • Hervé Tainturier, General Counsel, Sanofi Pasteur SA
  • Jalil Asif, 4 New Square
  • David Body, Irwin Mitchell Solicitors
  • Eric Duranson, Legal Affairs, Sanofi Pasteur SA
  • Gregory Loss, Chadbourne & Parke LL
  • Simon Pearl, Davies Arnold Cooper
  • Anne Ware, Covington & Burling

Papers & Proceedings

Members of the Institute and of the Product Liability Forum can access materials from this event by clicking here.

Receive Events Updates

If you would like to receive information on events of this type from the Institute in future, please sign up to the website.

Topics:

  • Recent Developments in US Pharmaceutical Regulation: Update on FDA Physician Labelling Rule
  • The importance of dialogue between regulators
  • 'The changing shape of Pharmaceutical risk'
  • The PREP Act: Liability Protection to Ensure Public Health Protection Against Pandemic Flu
  • Regulation under the scrutiny of the Media
  • The financial impact of pharmaceutical regulation and litigation
  • Obstacles to access to justice in pharmaceutical cases
  • A worldwide Forum?
  • European trends in pharmaceutical litigation
  • US trends in pharmaceutical litigation
  • Liability arising from clinical trials
  • Global regulation of pharmaceuticals: dialogue, efficiency, safety
  • Challenges of a world-wide pharmaceutical law suit

7 CPD hours may be claimed by both solicitors and barristers through attendance at this event.

This event has been kindly sponsored by

4 New Square Logo Lovells

Institute members may access papers from this event by following this link.